astrazeneca plc (ZEG:XETRA Level 1)
Last €40.24 EUR
Change Today +0.098 / 0.24%
Volume 1.2K
As of 10:15 AM 05/20/13 All times are local (Market data is delayed by at least 15 minutes).
Audit Committee* - astrazeneca plc (ZEG)
| Name (Connections) | Board Relationships | Title | Key Developments |
| Rudolph Markham | 90 Relationships | Non Executive Director, Chairman of Audit Committee, Member of Remuneration Committee and Member of Nomination & Governance Committee | Astrazeneca Announces Revised Results for the Year 2003 and First Half of 2004 10/25/04 |
| Jean-Philippe Courtois | 63 Relationships | Non Executive Director and Member of Audit Committee | AstraZeneca's Marketing Of Drugs Is Investigated 03/11/03 |
| Bruce Burlington M.D. | 30 Relationships | Non-Executive Director, Member of Science Committee and Member of Audit Committee | |
| Shriti Vadera MA | 25 Relationships | Director and Member of Audit Committee | |
| Graham Chipchase | 17 Relationships | Non-Executive Director and Member of Audit Committee |
Nominating Committee* - astrazeneca plc (ZEG)
| Name (Connections) | Board Relationships | Title | Key Developments |
| Leif Johansson MSc Eng. | 95 Relationships | Non-Executive Chairman, Chairman of Nomination & Governance Committee and Member of Remuneration Committee | AstraZeneca PLC Appoints Marc Dunoyer as Executive Vice President, Global Portfolio & Product Strategy 03/21/13 |
| Dame Rothwell FRS | 11 Relationships | Non Executive Director, Chairman of Science Committee, Member of Nomination & Governance Committee and Member of Remuneration Committee | AstraZeneca PLC Announces Changes in Leadership Team 02/18/13 |
| John Varley BA, MA (Oxon) | 42 Relationships | Senior Independent Non-Executive Director, Chairman of Remuneration Committee and Member of Nomination & Governance Committee | AstraZeneca PLC Announces Executive Changes 01/15/13 |
| Rudolph Markham | 90 Relationships | Non Executive Director, Chairman of Audit Committee, Member of Remuneration Committee and Member of Nomination & Governance Committee | AstraZeneca PLC Appoints Joan Shaw as Senior Director of Clinical Operations 01/11/13 |
*Data is at least as current as the most recent Definitive Proxy.
| Recently Viewed | |||
| ZEG:GR | €40.24 EUR | +0.098 |  |
| Company | Last | Change |
| Abbott Laboratories | $37.81 USD | +1.22 |
| Biogen Idec Inc | $225.18 USD | -1.67 |
| Bristol-Myers Squibb Co | $43.76 USD | +0.46 |
| Eli Lilly & Co | $55.02 USD | -0.88 |
| Novo Nordisk A/S | kr995.00 DKK | -3.00 |
| View Industry Companies | ||
Industry Analysis
ZEG
Industry Average
| Valuation | ZEG | Industry Range |
| Price/Earnings | 11.4x |
|
| Price/Sales | 2.4x |
|
| Price/Book | 2.9x |
|
| Price/Cash Flow | 11.4x |
|
| TEV/Sales | 2.4x |
|
Post a JobJobs
- New York, NY |Posted: May 17
- San Francisco, CA | YelpPosted: May 02
- San Francisco, CA | YelpPosted: May 02
- Northglenn, CO | Office DepotPosted: Mar 01
Sponsored Financial Commentaries
Sponsored Links
Report Data Issue
To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Please enter your information in the following field(s):
Your requested update has been submitted
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
